Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$896,880
+$1,955 QoQ
Shares Held
10,528
-22.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds $24,827,558 across 10 Biotechnology names. CYTK ranks #3 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
161,250 | $11,392,312 | |
| 2 | 81,645 | $10,836,740 | |||
| 3 | CYTK |
Cytokinetics Inc
This page
|
10,528 | $896,880 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,450 | $833,396 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,500 | $335,160 | |
| 6 | INSM |
INSMED Inc
|
2,500 | $266,550 | |
| 7 | ABVX |
Abivax S.A.
|
2,000 | $266,520 | |
| 8 | 159,003 | $0 |
All Filings in CYTK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $896,880 | 10,528 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $894,925 | 13,578 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $862,746 | 13,578 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,059,790 | 37,478 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||